Gene · 1460
Papers1,702
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,702
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation. | Haematologica | 2023 | 36226498 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise. | Mol Cell Biochem | 2023 | 36114992 | PubTator, text mining | PubMed |
| Chemical composition and therapeutic mechanism of Xuanbai Chengqi Decoction in the treatment of COVID-19 by network pharmacology, molecular docking and molecular dynamic analysis. | Mol Divers | 2023 | 35258759 | PubTator, text mining | PubMed |
| TF-Prioritizer: a Java pipeline to prioritize condition-specific transcription factors. | Gigascience | 2022 | 37132521 | PubTator, text mining | PubMed |
| Identification of ULK1 as a novel mitophagy-related gene in diabetic nephropathy. | Front Endocrinol (Lausanne) | 2022 | 36743936 | PubTator, text mining | PubMed |
| CK2β-regulated signaling controls B cell differentiation and function. | Front Immunol | 2022 | 36713383 | PubTator, text mining | PubMed |
| Perspectives on lecithin from egg yolk: Extraction, physicochemical properties, modification, and applications. | Front Nutr | 2022 | 36687715 | PubTator, text mining | PubMed |
| CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model. | Biomedicines | 2022 | 36672551 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of the Effects of Key Mitophagy Genes on the Progression and Prognosis of Lung Adenocarcinoma. | Cancers (Basel) | 2022 | 36612054 | PubTator, text mining | PubMed |
| The molecular basis of the dichotomous functionality of MAP4K4 in proliferation and cell motility control in cancer. | Front Oncol | 2022 | 36568222 | PubTator, text mining | PubMed |
| Yeast Protein Asf1 Possesses Modulating Activity towards Protein Kinase CK2. | Int J Mol Sci | 2022 | 36555405 | PubTator, text mining | PubMed |
| In Skeletal Muscle Fibers, Protein Kinase Subunit CSNK2A1/CK2α Is Required for Proper Muscle Homeostasis and Structure and Function of Neuromuscular Junctions. | Cells | 2022 | 36552726 | PubTator, text mining | PubMed |
| Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma. | Front Genet | 2022 | 36544483 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals differential cell subpopulations and distinct phenotype transition in normal and dissected ascending aorta. | Mol Med | 2022 | 36536281 | PubTator, text mining | PubMed |
| Editorial: Casein kinases in human diseases. | Front Mol Biosci | 2022 | 36533071 | PubTator, text mining | PubMed |
| Mechanism of herpesvirus protein kinase UL13 in immune escape and viral replication. | Front Immunol | 2022 | 36531988 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| Upregulated FKBP1A Suppresses Glioblastoma Cell Growth via Apoptosis Pathway. | Int J Mol Sci | 2022 | 36499275 | PubTator, text mining | PubMed |
| De novo emergence, existence, and demise of a protein-coding gene in murids. | BMC Biol | 2022 | 36482406 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1460/papers?page=9